Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.

Stanley W. Peters, III net worth and biography

Stanley Peters, III Biography and Net Worth

VP of CONMED

STANLEY W. (BILL) PETERS joined the Company as Vice President and General Manager, U.S. Advanced Surgical in January 2015. Prior to joining the Company, Mr. Peters served as Director of Sales for Mako Surgical Corporation from 2012 to 2014. Mako was purchased by Stryker Corporation in December 2013. Prior to this, Mr. Peters served as an executive with EndoGastric Solutions from 2011 to 2012 and in sales leadership roles at Intuitive Surgical from 2009 to 2011. Prior to Intuitive Surgical, Mr. Peters was employed at Stryker Corporation in sales leadership from 2004 to 2009. Mr. Peters graduated from Ohio University with a B.B.A. degree in Finance.

What is Stanley W. Peters, III's net worth?: The estimated net worth of Stanley W. Peters, III is at least $4,453.47 as of June 14th, 2024. Mr. Peters, III owns 63 shares of CONMED stock worth more than $4,453 as of November 21st. This net worth evaluation does not reflect any other assets that Mr. Peters, III may own. Learn More about Stanley W. Peters, III's net worth.
How do I contact Stanley W. Peters, III?: The corporate mailing address for Mr. Peters, III and other CONMED executives is 525 FRENCH ROAD, UTICA NY, 13502. CONMED can also be reached via phone at (727) 392-6464. Learn More on Stanley W. Peters, III's contact information.
Has Stanley W. Peters, III been buying or selling shares of CONMED?: Stanley W. Peters, III has not been actively trading shares of CONMED in the last ninety days. Most recently, Stanley W. Peters III sold 4,000 shares of the business's stock in a transaction on Friday, June 14th. The shares were sold at an average price of $71.82, for a transaction totalling $287,280.00. Following the completion of the sale, the insider now directly owns 63 shares of the company's stock, valued at $4,524.66. Learn More on Stanley W. Peters, III's trading history.
Who are CONMED's active insiders?: CONMED's insider roster includes Pat Beyer (Insider), Brian Concannon (Director), Todd Garner (CFO), Curt Hartman (Chairman of the Board, CEO & President), Daniel Jonas (Insider), John Kennedy (EVP), Stanley Peters, III (VP), Peter Shagory (EVP), and Mark Tryniski (Director). Learn More on CONMED's active insiders.
Are insiders buying or selling shares of CONMED?: In the last twelve months, CONMED insiders bought shares 3 times. They purchased a total of 6,442 shares worth more than $446,732.92. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 6,300 shares worth more than $540,119.00. The most recent insider tranaction occured on June, 14th when insider Stanley W Peters III sold 4,000 shares worth more than $287,280.00. Insiders at CONMED own 6.8% of the company. Learn More about insider trades at CONMED.
Information on this page was last updated on 6/14/2024.

Stanley W. Peters, III Insider Trading History at CONMED

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/14/2024	Sell	4,000	$71.82	$287,280.00	63
12/4/2023	Sell	2,300	$109.93	$252,839.00	63
11/7/2023	Sell	1,200	$102.39	$122,868.00	63
9/13/2023	Sell	2,000	$107.31	$214,620.00	63
6/8/2023	Sell	5,000	$131.14	$655,700.00	63
5/22/2023	Sell	1,500	$120.89	$181,335.00	63

Stanley W. Peters, III Buying and Selling Activity at CONMED

CONMED Company Overview

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Today's Range

Now: $70.69

$70.27

$72.10

50 Day Range

MA: $69.64

$61.80

$76.93

2 Week Range

Now: $70.69

$61.05

$117.27

Volume

262,558 shs

Average Volume

487,489 shs

Market Capitalization

$2.18 billion

P/E Ratio

16.79

Dividend Yield

1.11%

Beta

1.45

Download Our Tesla Ebook For Free

From DTI | Ad